How Autophagy Shapes the Tumor Microenvironment in Ovarian Cancer
Tóm tắt
Ovarian cancer (OC) is characterized by a high mortality rate due to the late diagnosis and the elevated metastatic potential. Autophagy, a lysosomal-driven catabolic process, contributes to the macromolecular turnover, cell homeostasis, and survival, and as such, it represents a pathway targetable for anti-cancer therapies. It is now recognized that the vascularization and the cellular composition of the tumor microenvironment influence the development and progression of OC by controlling the availability of nutrients, oxygen, growth factors, and inflammatory and immune-regulatory soluble factors that ultimately impinge on autophagy regulation in cancer cells. An increasing body of evidence indicates that OC carcinogenesis is associated, at least in the early stages, to insufficient autophagy. On the other hand, when the tumor is already established, autophagy activation provides a survival advantage to the cancer cells that face metabolic stress and protects from the macromolecules and organelles damages induced by chemo- and radiotherapy. Additionally, upregulation of autophagy may lead cancer cells to a non-proliferative dormant state that protects the cells from toxic injuries while preserving their stem-like properties. Further to complicate the picture, autophagy is deregulated also in stromal cells. Thus, changes in the tumor microenvironment reflect on the metabolic crosstalk between cancer and stromal cells impacting on their autophagy levels and, consequently, on cancer progression. Here, we present a brief overview of the role of autophagy in OC hallmarks, including tumor dormancy, chemoresistance, metastasis, and cell metabolism, with an emphasis on the bidirectional metabolic crosstalk between cancer cells and stromal cells in shaping the OC microenvironment.
Từ khóa
Tài liệu tham khảo
Cabasag, 2020, The influence of birth cohort and calendar period on global trends in ovarian cancer incidence, Int J Cancer, 146, 10.1002/ijc.32322
Cook, 2019, Ovarian cancer and the evolution of subtype classifications using transcriptional profiling, Biol Reprod, 101, 10.1093/biolre/ioz099
Coleman, 2013, Latest research and treatment of advanced-stage epithelial ovarian cancer, Nat Rev Clin Oncol, 10, 10.1038/nrclinonc.2013.5
Kipps, 2013, Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research, Nat Rev Cancer, 13, 10.1038/nrc3432
Klymenko, 2018, Epigenetic Crosstalk between the Tumor Microenvironment and Ovarian Cancer Cells: A Therapeutic Road Less Traveled, Cancers (Basel), 10, pii: E295, 10.3390/cancers10090295
Langley, 2011, The seed and soil hypothesis revisited–the role of tumor-stroma interactions in metastasis to different organs, Int J Cancer, 128, 10.1002/ijc.26031
Lili, 2013, Molecular profiling predicts the existence of two functionally distinct classes of ovarian cancer stroma, BioMed Res Int, 2013, 10.1155/2013/846387
Guo, 2016, Autophagy, Metabolism, and Cancer, Cold Spring Harb Symp Quant Biol, 81, 10.1101/sqb.2016.81.030981
Wojtkowiak, 2012, Chronic autophagy is a cellular adaptation to tumor acidic pH microenvironments, Cancer Res, 72, 10.1158/0008-5472.CAN-11-3881
Yang, 2015, The role of autophagy induced by tumor microenvironment in different cells and stages of cancer, Cell Biosci, 5, 14, 10.1186/s13578-015-0005-2
Kroemer, 2010, Autophagy and the integrated stress response, Mol Cell, 40, 10.1016/j.molcel.2010.09.023
Maes, 2013, Autophagy: shaping the tumor microenvironment and therapeutic response, Trends Mol Med, 19, 10.1016/j.molmed.2013.04.005
Folkerts, 2019, The multifaceted role of autophagy in cancer and the microenvironment, Med Res Rev, 39, 10.1002/med.21531
Ngabire, 2017, Autophagy and Inflammatory Response in the Tumor Microenvironment, Int J Mol Sci, 18, 10.3390/ijms18092016
Jiang, 2020, Targeting tumor microenvironment in ovarian cancer: Premise and promise, Biochim Biophys Acta Rev Cancer, 1873, 10.1016/j.bbcan.2020.188361
Worzfeld, 2017, The Unique Molecular and Cellular Microenvironment of Ovarian Cancer, Front Oncol, 7, 10.3389/fonc.2017.00024
Thuwajit, 2018, The metabolic cross-talk between epithelial cancer cells and stromal fibroblasts in ovarian cancer progression: Autophagy plays a role, Med Res Rev, 38, 10.1002/med.21473
Ahmed, 2018, Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells, Semin Cancer Biol, 53, 10.1016/j.semcancer.2018.10.002
Nowak, 2010, Proinflammatory and immunosuppressive serum, ascites and cyst fluid cytokines in patients with early and advanced ovarian cancer and benign ovarian tumors, Neuro Endocrinol Lett, 31
Rainczuk, 2012, The emerging role of CXC chemokines in epithelial ovarian cancer, Reproduction, 144, 10.1530/REP-12-0153
Kuma, 2010, Physiological role of autophagy as an intracellular recycling system: with an emphasis on nutrient metabolism, Semin Cell Dev Biol, 21, 10.1016/j.semcdb.2010.03.002
Parzych, 2014, An overview of autophagy: morphology, mechanism, and regulation, Antioxid Redox Signal, 20, 10.1089/ars.2013.5371
Mathew, 2014, Functional role of autophagy-mediated proteome remodeling in cell survival signaling and innate immunity, Mol Cell, 55, 10.1016/j.molcel.2014.07.019
Ma, 2020, Mitophagy, Mitochondrial Homeostasis, and Cell Fate, Front Cell Dev Biol, 8, 10.3389/fcell.2020.00467
Amaravadi, 2019, Targeting Autophagy in Cancer: Recent Advances and Future Directions, Cancer Discovery, 9, 10.1158/2159-8290.CD-19-0292
Wang, 2020, The Role of Mitochondrial Dynamics and Mitophagy in Carcinogenesis, Metastasis and Therapy, Front Cell Dev Biol, 8, 10.3389/fcell.2020.00413
White, 2012, Deconvoluting the context-dependent role for autophagy in cancer, Nat Rev Cancer, 12, 10.1038/nrc3262
Ho, 2019, Molecular Mechanisms Underlying Autophagy-Mediated Treatment Resistance in Cancer, Cancers (Basel), 11, 10.3390/cancers11111775
Pérez-Hernández, 2019, Targeting Autophagy for Cancer Treatment and Tumor Chemosensitization, Cancers (Basel), 11, 10.3390/cancers11101599
Goldsmith, 2014, Autophagy and cancer metabolism, Methods Enzymol, 542, 25, 10.1016/B978-0-12-416618-9.00002-9
Peracchio, 2012, Involvement of autophagy in ovarian cancer: a working hypothesis, J Ovarian Res, 5, 10.1186/1757-2215-5-22
Zhan, 2016, Autophagy as an emerging therapy target for ovarian carcinoma, Oncotarget, 7, 10.18632/oncotarget.13080
Qu, 2003, Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene, J Clin Invest, 112, 10.1172/JCI20039
Delaney, 2020, Autophagy gene haploinsufficiency drives chromosome instability, increases migration, and promotes early ovarian tumors, PloS Genet, 16, e1008558, 10.1371/journal.pgen.1008558
Lapinska, 2016, The Effects of Histone Deacetylase Inhibitor and Calpain Inhibitor Combination Therapies on Ovarian Cancer Cells, Anticancer Res, 36, 10.21873/anticanres.11156
Liao, 2014, Hypomethylation signature of tumor-initiating cells predicts poor prognosis of ovarian cancer patients, Hum Mol Genet, 23, 10.1093/hmg/ddt583
Titone, 2014, Epigenetic control of autophagy by microRNAs in ovarian cancer, BioMed Res Int, 2014, 10.1155/2014/343542
Ferraresi, 2017, Resveratrol inhibits IL-6-induced ovarian cancer cell migration through epigenetic up-regulation of autophagy, Mol Carcinog, 56, 10.1002/mc.22582
Vallino, 2020, Modulation of non-coding RNAs by resveratrol in ovarian cancer cells: In silico analysis and literature review of the anti-cancer pathways involved, J Tradit Complement Med, 10, 10.1016/j.jtcme.2020.02.006
Still, 2017, Hopefully devoted to Q: targeting glutamine addiction in cancer, Br J Cancer, 116, 10.1038/bjc.2017.113
Pavlides, 2009, The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma, Cell Cycle, 8, 3984, 10.4161/cc.8.23.10238
Lisanti, 2013, Oncogenes induce the cancer-associated fibroblast phenotype: metabolic symbiosis and “fibroblast addiction” are new therapeutic targets for drug discovery, Cell Cycle, 12, 10.4161/cc.25695
Fiaschi, 2012, Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay, Cancer Res, 72, 10.1158/0008-5472.CAN-12-1949
Bhutia, 2015, Amino Acid transporters in cancer and their relevance to “glutamine addiction”: novel targets for the design of a new class of anticancer drugs, Cancer Res, 75, 10.1158/0008-5472.CAN-14-3745
Kaur, 2015, Autophagy at the crossroads of catabolism and anabolism, Nat Rev Mol Cell Biol, 16, 10.1038/nrm4024
Ferraresi, 2017, The protein restriction mimetic Resveratrol is an autophagy inducer stronger than amino acid starvation in ovarian cancer cells, Mol Carcinog, 56, 10.1002/mc.22711
Meijer, 2015, Regulation of autophagy by amino acids and MTOR-dependent signal transduction, Amino Acids, 47, 10.1007/s00726-014-1765-4
Follo, 2019, Amino acid response by Halofuginone in Cancer cells triggers autophagy through proteasome degradation of mTOR, Cell Commun Signal, 17, 39, 10.1186/s12964-019-0354-2
Shuvayeva, 2014, Single amino acid arginine deprivation triggers prosurvival autophagic response in ovarian carcinoma SKOV3, BioMed Res Int, 2014, 10.1155/2014/505041
Scalise, 2017, Glutamine Transport and Mitochondrial Metabolism in Cancer Cell Growth, Front Oncol, 7, 10.3389/fonc.2017.00306
Unterlass, 2019, Warburg and Krebs and related effects in cancer, Expert Rev Mol Med, 21, e4, 10.1017/erm.2019.4
Benjamin, 2012, Global profiling strategies for mapping dysregulated metabolic pathways in cancer, Cell Metab, 16, 10.1016/j.cmet.2012.09.013
Caneba, 2012, Pyruvate uptake is increased in highly invasive ovarian cancer cells under anoikis conditions for anaplerosis, mitochondrial function, and migration, Am J Physiol Endocrinol Metab, 303, E1036, 10.1152/ajpendo.00151.2012
Yang, 2014, Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer, Mol Syst Biol, 10, 728, 10.1002/msb.20134892
Yuan, 2015, Glutamine promotes ovarian cancer cell proliferation through the mTOR/S6 pathway, Endocr Relat Cancer, 22, 10.1530/ERC-15-0192
Furusawa, 2018, Ovarian cancer therapeutic potential of glutamine depletion based on GS expression, Carcinogenesis, 39, 10.1093/carcin/bgy033
Roberts, 2014, Hexokinase-II positively regulates glucose starvation-induced autophagy through TORC1 inhibition, Mol Cell, 53, 10.1016/j.molcel.2013.12.019
Porporato, 2011, Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review, Front Pharmacol, 2, 10.3389/fphar.2011.00049
Liberti, 2016, The Warburg Effect: How Does it Benefit Cancer Cells, Trends Biochem Sci, 41, 10.1016/j.tibs.2015.12.001
Moreno-Sánchez, 2007, Energy metabolism in tumor cells, FEBS J, 274, 10.1111/j.1742-4658.2007.05686.x
Vander Heiden, 2009, Understanding the Warburg effect: the metabolic requirements of cell proliferation, Science, 324, 10.1126/science.1160809
Estrella, 2013, Acidity generated by the tumor microenvironment drives local invasion, Cancer Res, 73, 10.1158/0008-5472.CAN-12-2796
Varum, 2011, Energy metabolism in human pluripotent stem cells and their differentiated counterparts, PloS One, 6, e20914, 10.1371/journal.pone.0020914
Xu, 2017, EGF induces epithelial-mesenchymal transition and cancer stem-like cell properties in human oral cancer cells via promoting Warburg effect, Oncotarget, 8, 10.18632/oncotarget.13771
Dhup, 2012, Multiple biological activities of lactic acid in cancer: influences on tumor growth, angiogenesis and metastasis, Curr Pharm Des, 18, 10.2174/138161212799504902
Ho, 2015, Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses, Cell, 162, 10.1016/j.cell.2015.08.012
Chang, 2015, Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression, Cell, 162, 10.1016/j.cell.2015.08.016
Colegio, 2014, Functional polarization of tumour-associated macrophages by tumour-derived lactic acid, Nature, 513, 10.1038/nature13490
Icard, 2014, The metabolic cooperation between cells in solid cancer tumors, Biochim Biophys Acta, 1846, 10.1016/j.bbcan.2014.06.002
Icard, 2018, How the Warburg effect supports aggressiveness and drug resistance of cancer cells, Drug Resist Updat, 38, 1, 10.1016/j.drup.2018.03.001
Carito, 2012, Metabolic remodeling of the tumor microenvironment: migration stimulating factor (MSF) reprograms myofibroblasts toward lactate production, fueling anabolic tumor growth, Cell Cycle, 11, 10.4161/cc.21701
Yan, 2019, The effects and the mechanisms of autophagy on the cancer-associated fibroblasts in cancer, J Exp Clin Cancer Res, 38, 171, 10.1186/s13046-019-1172-5
Brisson, 2016, Lactate Dehydrogenase B Controls Lysosome Activity and Autophagy in Cancer, Cancer Cell, 30, 10.1016/j.ccell.2016.08.005
Nieman, 2011, Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth, Nat Med, 17, 10.1038/nm.2492
Motohara, 2019, An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment, Oncogene, 38, 10.1038/s41388-018-0637-x
Schumann, 2015, Deregulation of PPARβ/δ target genes in tumor-associated macrophages by fatty acid ligands in the ovarian cancer microenvironment, Oncotarget, 6, 10.18632/oncotarget.3826
Chen, 2019, Targeting of lipid metabolism with a metabolic inhibitor cocktail eradicates peritoneal metastases in ovarian cancer cells, Commun Biol, 2, 281, 10.1038/s42003-019-0508-1
Nieman, 2013, Adipose tissue and adipocytes support tumorigenesis and metastasis, Biochim Biophys Acta, 1831, 10.1016/j.bbalip.2013.02.010
Lengyel, 2018, Cancer as a Matter of Fat: The Crosstalk between Adipose Tissue and Tumors, Trends Cancer, 4, 10.1016/j.trecan.2018.03.004
Ladanyi, 2018, Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis, Oncogene, 37, 10.1038/s41388-017-0093-z
Li, 2019, CD36 plays a negative role in the regulation of lipophagy in hepatocytes through an AMPK-dependent pathway, J Lipid Res, 60, 10.1194/jlr.M090969
Maan, 2018, Lipid metabolism and lipophagy in cancer, Biochem Biophys Res Commun, 504, 10.1016/j.bbrc.2018.02.097
Wen, 2017, Adipocytes activate mitochondrial fatty acid oxidation and autophagy to promote tumor growth in colon cancer, Cell Death Dis, 8, e2593, 10.1038/cddis.2017.21
Seyfried, 2014, Cancer as a metabolic disease: implications for novel therapeutics, Carcinogenesis, 35, 10.1093/carcin/bgt480
Lyssiotis, 2017, Metabolic Interactions in the Tumor Microenvironment, Trends Cell Biol, 27, 10.1016/j.tcb.2017.06.003
Zhao, 2015, Activation of mTOR pathway in myeloid-derived suppressor cells stimulates cancer cell proliferation and metastasis in lal(-/-) mice, Oncogene, 34, 10.1038/onc.2014.143
Kounakis, 2019, Emerging Roles of Lipophagy in Health and Disease, Front Cell Dev Biol, 7, 10.3389/fcell.2019.00185
Keulers, 2016, Autophagy-Dependent Secretion: Contribution to Tumor Progression, Front Oncol, 6, 10.3389/fonc.2016.00251
Dupont, 2011, Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1β, EMBO J, 30, 10.1038/emboj.2011.398
Maycotte, 2015, Autophagy Supports Breast Cancer Stem Cell Maintenance by Regulating IL6 Secretion, Mol Cancer Res, 13, 10.1158/1541-7786.MCR-14-0487
Salah, 2016, Tumor suppression in mice lacking GABARAP, an Atg8/LC3 family member implicated in autophagy, is associated with alterations in cytokine secretion and cell death, Cell Death Dis, 7, e2205, 10.1038/cddis.2016.93
Zhan, 2014, Autophagy facilitates TLR4- and TLR3-triggered migration and invasion of lung cancer cells through the promotion of TRAF6 ubiquitination, Autophagy, 10, 10.4161/auto.27162
Kraya, 2015, Identification of secreted proteins that reflect autophagy dynamics within tumor cells, Autophagy, 11, 60, 10.4161/15548627.2014.984273
Cotzomi-Ortega, 2018, Autophagy and Its Role in Protein Secretion: Implications for Cancer Therapy, Mediators Inflamm, 2018, 10.1155/2018/4231591
New, 2017, Secretory Autophagy in Cancer-Associated Fibroblasts Promotes Head and Neck Cancer Progression and Offers a Novel Therapeutic Target, Cancer Res, 77, 10.1158/0008-5472.CAN-17-1077
Nüchel, 2018, TGFB1 is secreted through an unconventional pathway dependent on the autophagic machinery and cytoskeletal regulators, Autophagy, 14, 10.1080/15548627.2017.1422850
Wei, 2011, Suppression of autophagy by FIP200 deletion inhibits mammary tumorigenesis, Genes Dev, 25, 10.1101/gad.2051011
Martins, 2014, Molecular mechanisms of ATP secretion during immunogenic cell death, Cell Death Differ, 21, 79, 10.1038/cdd.2013.75
Michaud, 2011, Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice, Science, 334, 10.1126/science.1208347
Dvorak, 2015, Tumors: wounds that do not heal-redux, Cancer Immunol Res, 3, 1, 10.1158/2326-6066.CIR-14-0209
Cadwell, 2016, Crosstalk between autophagy and inflammatory signalling pathways: balancing defence and homeostasis, Nat Rev Immunol, 16, 10.1038/nri.2016.100
Martinez-Outschoorn, 2011, Cytokine production and inflammation drive autophagy in the tumor microenvironment: role of stromal caveolin-1 as a key regulator, Cell Cycle, 10, 10.4161/cc.10.11.15674
Monkkonen, 2018, Inflammatory signaling cascades and autophagy in cancer, Autophagy, 14, 10.1080/15548627.2017.1345412
Thongchot, 2018, Resveratrol interrupts the pro-invasive communication between cancer associated fibroblasts and cholangiocarcinoma cells, Cancer Lett, 430, 10.1016/j.canlet.2018.05.031
Wang, 2012, Interleukin-6 signaling regulates anchorage-independent growth, proliferation, adhesion and invasion in human ovarian cancer cells, Cytokine, 59, 10.1016/j.cyto.2012.04.020
Ha, 2018, LPA Induces Metabolic Reprogramming in Ovarian Cancer via a Pseudohypoxic Response, Cancer Res, 78, 10.1158/0008-5472.CAN-17-1624
Ha, 2016, Lysophosphatidic acid stimulates epithelial to mesenchymal transition marker Slug/Snail2 in ovarian cancer cells via Gαi2, Src, and HIF1α signaling nexus, Oncotarget, 7, 10.18632/oncotarget.9224
Jeon, 2010, Ovarian cancer-derived lysophosphatidic acid stimulates secretion of VEGF and stromal cell-derived factor-1 alpha from human mesenchymal stem cells, Exp Mol Med, 42, 10.3858/emm.2010.42.4.027
Fang, 2004, Mechanisms for lysophosphatidic acid-induced cytokine production in ovarian cancer cells, J Biol Chem, 279, 10.1074/jbc.M306662200
Chang, 2007, Lysophosphatidic acid inhibits serum deprivation-induced autophagy in human prostate cancer PC-3 cells, Autophagy, 3, 10.4161/auto.3909
Genc, 2018, Lysophosphatidic acid represses autophagy in prostate carcinoma cells, Biochem Cell Biol, 97, 10.1139/bcb-2018-0164
Radhakrishnan, 2019, Ovarian cancer cell-derived lysophosphatidic acid induces glycolytic shift and cancer-associated fibroblast-phenotype in normal and peritumoral fibroblasts, Cancer Lett, 442, 10.1016/j.canlet.2018.11.023
Kuo, 2019, In vivo selection reveals autophagy promotes adaptation of metastatic ovarian cancer cells to abdominal microenvironment, Cancer Sci, 110, 10.1111/cas.14162
Gugnoni, 2016, Autophagy and epithelial-mesenchymal transition: an intricate interplay in cancer, Cell Death Dis, 7, e2520, 10.1038/cddis.2016.415
Catalano, 2015, Autophagy induction impairs migration and invasion by reversing EMT in glioblastoma cells, Mol Oncol, 9, 10.1016/j.molonc.2015.04.016
Qiang, 2014, Autophagy deficiency stabilizes TWIST1 to promote epithelial-mesenchymal transition, Autophagy, 10, 10.4161/auto.32171
Vera-Ramirez, 2017, Tumor cell dormancy as an adaptive cell stress response mechanism, F1000Res, 6, 2134, 10.12688/f1000research.12174.1
Aguirre-Ghiso, 2007, Models, mechanisms and clinical evidence for cancer dormancy, Nat Rev Cancer, 7, 10.1038/nrc2256
Gao, 2017, Cancer cell dormancy: mechanisms and implications of cancer recurrence and metastasis, Onco Targets Ther, 10, 10.2147/OTT.S140854
Lu, 2014, DIRAS3 regulates the autophagosome initiation complex in dormant ovarian cancer cells, Autophagy, 10, 10.4161/auto.28577
Lu, 2008, The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells, J Clin Invest, 118, 10.1172/JCI35512
Sutton, 2019, Amino Acid Deprivation-Induced Autophagy Requires Upregulation of DIRAS3 through Reduction of E2F1 and E2F4 Transcriptional Repression, Cancers (Basel), 11, pii: E603, 10.3390/cancers11050603
Lee, 2012, Atg7 modulates p53 activity to regulate cell cycle and survival during metabolic stress, Science, 336, 10.1126/science.1218395